Purpose To perform a systematic review and meta-analysis to determine if there are
differences in rates of immediate allergic events between classes of gadolinium-based …

The risk for developing immediate or delayed hypersensitivity reactions to radiocontrast
media (RCM) interferes with the diagnosis and treatment of a number of patients requiring …

Immediate and nonimmediate hypersensitivity reactions to iodinated contrast media (ICM)
have been reported to occur in a frequency of about 0.5%‐3% of patients receiving nonionic …

Diagnosing immediate drug hypersensitivity reactions (IDHRs) can pose a significant
challenge and there is an urgent need for safe and reliable tests. Evidence has emerged …

Background Iodinated and gadolinium-based contrast media (ICM; GBCM) induce
immediate hypersensitivity (IH) reactions. Differentiating allergic from non-allergic IH is …

Background The management of iodinated contrast medium (ICM) hypersensitivity has been
a matter of debate. Skin testing to identify a subgroup of ICM allergic patients has been …

Drug hypersensitivity reactions (DHR) are heterogeneous in their pathomechanisms, clinical
presentation, severity, and outcomes. Novel DHR mechanisms, phenotypes, and endotypes …

At present, iodinated contrast media (ICM) are mostly non-ionic, have low osmolality, and
are safe. Even if adverse drug reactions (ADRs) occur, most are chemo-toxic symptoms and …

Objectives We aimed to meta-analytically compare the incidence of acute adverse reactions
(AARs) to nonionic iodinated contrast media (ICM) according to the type of ICM in patients …

Abstract Adverse Drug Reactions (ADRs) are common and influence negatively the patient's
therapeutic options. They recognize multiple pathogenic mechanisms, some of …